The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec.

The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec.

Publication date: Sep 24, 2025

Concepts Keywords
Covid ADAMTS-13
Laboratory COVID-19
Microangiopathies Epidemiology
Quebec Incidence
Thrombotic Thrombotic microangiopathy
Thrombotic thrombocytopenic purpura

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH thrombotic microangiopathies
disease MESH Thrombotic thrombocytopenic purpura

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *